{
  "id": "clinical#screening_cues_71c9056c",
  "content": "medications, including withdrawal effects\nWhen establishing a diagnosis of secondary neurocognitive syndrome, it is important to rule out\nthe possibility that a medication or substance is causing the deficits in neurocognitive functioning\ninstead of – or in addition to – an underlying medical condition. This involves first considering\nwhether any of the medications being used to treat the medical condition are known to cause\ndeficits in cognitive functioning at the dose and duration at which it has been administered.\nSecond, a temporal relationship between the medication use and the onset of the deficits in\nneurocognitive functioning should be established (i.e. deficits in neurocognitive functioning\nbegan after administration of the medication and/or remitted once the medication was\ndiscontinued). The same reasoning applies to individuals with a medical condition who are using\na psychoactive substance known to cause deficits in neurocognitive functioning (e.g. memory\nloss due to sedative intoxication, disturbed attention/concentration and orientation due to\nalcohol intoxication). In such cases, delirium, amnestic disorder or dementia due to psychoactive\nsubstances (including medications) or mild neurocognitive disorder is the appropriate diagnosis,\napplying the appropriate category corresponding to the substance involved.\nSecondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "emotions",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues medications, including withdrawal effects\nWhen establishing a diagnosis of secondary neurocognitive syndrome, it is important to rule out\nthe possibility that a medication or substance is causing the deficits in neurocognitive functioning\ninstead of – or in addition to – an underlying medical condition. This involves first considering\nwhether any of the medications being used to treat the medical condition are known to cause\ndeficits in cognitive functioning at the dose and duration at which it has been administered.\nSecond, a temporal relationship between the medication use and the onset of the deficits in\nneurocognitive functioning should be established (i.e. deficits in neurocognitive functioning\nbegan after administration of the medication and/or remitted once the medication was\ndiscontinued). The same reasoning applies to individuals with a medical condition who are using\na psychoactive substance known to cause deficits in neurocognitive functioning (e.g. memory\nloss due to sedative intoxication, disturbed attention/concentration and orientation due to\nalcohol intoxication). In such cases, delirium, amnestic disorder or dementia due to psychoactive\nsubstances (including medications) or mild neurocognitive disorder is the appropriate diagnosis,\napplying the appropriate category corresponding to the substance involved.\nSecondary mental or behavioural syndromes associated with disorders and diseases classified elsewhere Medications, including withdrawal effects\nwhen establishing a diagnosis of secondary neurocognitive syndrome, it is important to rule out\nthe possibility that a medication or substance is causing the deficits in neurocog..."
}